SEC Form 4 · accession 0000059478-15-000058
ELI LILLY & Co · LLY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jan M Lundberg
Officer — EVP,Science&Tech and Pres. LRL
Period of report
Feb 1, 2015
Accepted (ET)
Feb 3, 2015 · 3:59 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000059478
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 1, 2015 | M | 20,985 | $0.00 | A | 220,116 | D | |
| Common Stock | Feb 1, 2015 | F | 9,900 | $72.00 | D | 210,216 | D | |
| Common StockF1 | Feb 2, 2015 | S | 50,000 | $70.87 | D | 160,216 | D | |
| Common StockF2 | Feb 3, 2015 | S | 71,711 | $70.72 | D | 88,505 | D | |
| Common Stock | holding | — | — | — | 1,006 | I | 401(k) |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF3 | — | Feb 1, 2015 | M | 20,985 | D | Feb 1, 2015 | Feb 1, 2015 | Common Stock | 20,985 | 0 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $70.74 to $71.01. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2This transaction was executed in multiple trades at prices ranging from $70.50 to $71.13. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.